跳至主要内容
临床试验/EUCTR2006-003933-33-DE
EUCTR2006-003933-33-DE进行中(未招募)不适用

Clinical value of Choline-Positron-Emission-Tomography combined with Magnetic Resonance Imaging by software fusion for pre-therapeutic staging of prostate cancer

Bundeswehr0 个研究点开始时间: 2006年9月6日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • - preoperative suspected prostate cancer (e.g. suspect digital rectal examination and/or PSA-Level >10,0 ng/ml)
  • - radical prostatectomy as primary treatment
  • - no nutrition within 12 hours before PET
  • - no food containing choline within 24 hous before PET
  • - age >50 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - total endo-prothesis of the hip region
  • - clinical or chemical detection of an acute infection
  • - missing patient agreement
  • - secondary cancer
  • - surgical treatment within 3 month before PET
  • - claustrophoby
  • - medical drugs with choline
  • - severe liver damage
  • - cardiac infarction
  • - Bradycardie (pulserate<55/min)
  • - allergic reaction against Neurotropan
  • - asthma bronchiale
  • - cardiac pacemaker
  • - each kind of small metall implants (e.g. clips, cochlea-implants, etc.)

研究者

发起方
Bundeswehr

相似试验